EVO Evotec SE Borsdata
Comprehensive stock information and analysis
Company Information
Sector:
Hälsovård
Industry:
Läkemedel
Exchange:
Nasdaq
Country:
USA
Key Metrics
Current Price:
1.60 USD
Market Cap:
$568.25
P/E Ratio:
-10.81
P/S Ratio:
1.41
P/B Ratio:
1.37
Dividend Yield:
0.00%
EPS:
-0.29 USD
Book Value / Share:
2.29 USD
Return on Equity:
-12.72%
Profit Margin:
-13.13%
Price Range
52 Week High:
4.27 USD
52 Week Low:
1.50 USD
Previous Close:
1.65 USD
Day High:
1.63 USD
Day Low:
1.59 USD
Summary Five-lens view · illustrative scores
Quick read on valuation, outlook, track record, balance sheet, and dividends from data on this page. Not investment advice; scores use rules-of-thumb when full statements are missing.
Rewards
- EPS grew ~3150% per year over available history
- Profit margin improved over recent completed years in KPIs
- High equity ratio — conservative capital structure in KPIs/reports
- Light net debt relative to book equity
Risks
- Negative P/E (loss-making on trailing basis)
- Negative or zero return on equity
A mixed picture across the scored dimensions. relative strength in forward outlook vs income orientation.
Key Performance Indicators Source: Borsdata_KpiHistory · annual (period=5) mean values · monetary KPIs in EUR
| KPI | Unit | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| P/E | — | -10.81 | -7.71 | -30.18 | -18.82 | 23.74 | 818.50 |
| P/S | — | 1.41 | 1.90 | 3.21 | 4.38 | 8.31 | 10.05 |
| P/B | — | 1.37 | 1.59 | 2.24 | 2.77 | 3.73 | 6.95 |
| Dividend Yield | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Earnings/share | EUR | -0.29 | -0.56 | -0.23 | -0.50 | 0.65 | 0.02 |
| Dividend | EUR | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value/share | EUR | 2.29 | 2.69 | 3.16 | 3.36 | 4.14 | 2.36 |
| Revenue/share | EUR | 2.22 | 2.25 | 2.21 | 2.13 | 1.86 | 1.63 |
| Return on Equity | % | -12.72 | -20.58 | -7.49 | -14.80 | 15.64 | 0.87 |
| Return on Assets | % | -6.04 | -10.25 | -3.72 | -7.78 | 9.64 | 0.43 |
| Gross margin | % | 14.49 | 14.41 | 22.40 | 23.16 | 24.52 | 25.10 |
| Operating margin | % | -7.08 | -9.90 | -3.41 | 2.78 | 6.74 | 10.34 |
| Profit margin | % | -13.13 | -24.60 | -10.74 | -23.38 | 34.87 | 1.25 |
| FCF margin% | % | -4.62 | -6.49 | -23.35 | -11.52 | 3.38 | -3.48 |
| Equity ratio | % | 47.48 | 49.81 | 49.72 | 52.59 | 61.64 | 49.54 |
| Net Debt | % | -0.89 | 3.97 | 0.98 | -8.89 | -15.46 | -0.05 |
Income statement flow Sankey · EUR · from annual income data
Revenue splits into cost of revenue and gross profit, then operating expenses and operating income, then residual items vs net earnings. Hover any node to see the historical margin range (low/high/average/median) computed from all years available in our database.
Financial Reports Source: Borsdata_Reports · all monetary values in EUR (the company's report currency; the stock trades in USD)
| Period | End Date | Revenue (EUR) | Operating Income (EUR) | Net Income (EUR) | EPS (EUR) | Dividend (EUR) | Free Cash Flow (EUR) | Total Assets (EUR) | Total Equity (EUR) | Net Debt (EUR) | Report Currency |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 2025-12-31 | 788 | -56 | -104 | -0.29 | 0.00 | -36 | 1,714 | 814 | -15 | EUR |
| 2024 | 2024-12-31 | 797 | -79 | -196 | -0.56 | 0.00 | -52 | 1,913 | 953 | 76 | EUR |
| 2023 | 2023-12-31 | 781 | -27 | -84 | -0.23 | 0.00 | -182 | 2,252 | 1,120 | 22 | EUR |
| 2022 | 2022-12-31 | 751 | 21 | -176 | -0.49 | 0.00 | -87 | 2,257 | 1,187 | -201 | EUR |
| 2021 | 2021-12-31 | 618 | 42 | 216 | 0.65 | 0.00 | 21 | 2,235 | 1,378 | -346 | EUR |
| 2020 | 2020-12-31 | 501 | 52 | 6 | 0.02 | 0.00 | -17 | 1,462 | 724 | -1 | EUR |
| 2019 | 2019-12-31 | 446 | 75 | 38 | 0.12 | 0.00 | 79 | 1,181 | 477 | 141 | EUR |
| 2018 | 2018-12-31 | 375 | 66 | 84 | 0.28 | 0.00 | 56 | 772 | 425 | -35 | EUR |
Price History
Loading chart data...